Status:
UNKNOWN
Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Collaborating Sponsors:
University Hospital, Tours
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Parkinson's disease is a frequent neurodegenerative disorder. Genetic forms of the disease have been recently identified. The monogenic form due to parkin mutation is responsible for many familial cas...
Eligibility Criteria
Inclusion
- Juvenile Parkinson's disease (\< 45 years)
- Parkin mutation
- Normal brain magnetic resonance imaging (MRI)
Exclusion
- Contraindication to brain MRI
- Women without effective contraception
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00169364
Start Date
May 1 2002
Last Update
August 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere
Paris, France